Surgical debridement and skin grafting are common clinical practices used in the management of chronic wounds1, burn wounds2, and acute wounds such as traumatic wounds3. Skin grafting refers to the surgical procedure, which involves the removal of healthy skin from one part of the body and transferring it to another. Donor grafts replace the lost tissue and provide a structural scaffold for cellular migration and growth. Following integration into the recipient site, skin grafts replace the lost skin barrier by providing protection from microbial invasion, harmful effects of the external environment and excessive loss of moisture4. Successful skin graft integration depends on several factors. These include adequate immune responses in the presence of microbial infections and timely resolution of inflammation, robust angiogenesis at the wound site and establishment of vascular anastomoses between the recipient bed and the donor graft5. As the graft begins to degrade, resident dermal cells must be replaced by cells capable of producing new extracellular matrix. At the same time, the epidermal keratinocytes must crawl over the newly produced matrix to form the neo-epidermis and re-epithelialize the wound. It is, therefore, evident that efficient migration of cells from the recipient bed into the donor graft is another determining factor that influences successful graft incorporation. Given the vast number of factors involved in wound healing6, which may be impossible to control in the human trials due to ethical limitations, models of pre-clinical experimental skin grafting are necessary. Development of pre-clinical models of burn wound healing and associated skin grafting will be important for understanding of complex mechanisms involved in cutaneous tissue repair and essential for the testing of new therapeutic agents. The in vitro models of wound healing are unable to accurately mimic the complexity of the cutaneous tissue. The in vivo animal models are an indispensable investigative tool in understanding the mechanisms involved in tissue repair.
Several methods of skin grafting technique were developed in rodents to mimic surgical excision and burn wound reconstruction7,8,9. However, most of the previously described procedures failed to induce a thermal burn injury prior to skin grafting. Instead of the burn wound, a full thickness excisional wound was induced, which was then reconstructed with a full thickness skin allograft7. Various anatomical landmarks such as the ear, tail and back have been used for harvesting of the donor skin in rodents7,8. Different graft fixation and stabilization techniques were reported, including a “no suture technique”9, sutures7 and surgical glue10,11,12.
The purpose of this study was to develop a murine model of a full thickness burn wound that would recapitulate the current gold standard approach in burn treatment, which involves nonviable tissue excision and skin grafting. A thermal burn was induced on the dorsum surface of a mouse using a preheated brass template. Burn eschar was excised and replaced with a full thickness graft harvested from the tail of a donor mouse. There are three key advantages to this experimental model. First, more than one burn wound may be induced on the back of the recipient mouse, and four donor skin grafts may be harvested from a single tail of the donor mouse. This means that several experimental and control treatments may potentially be compared using the same recipient and donor animals. Depending on the desired route of administration, the control treatment may include local or systemic administration of the vehicle or placebo control (e.g., topical application of ointment, subcutaneous, intraperitoneal or intravenous injection of solution). Second, timing of the treatment and the endpoint of the experiment may be controlled. Third, this model depends on the reconstruction of wounds using full thickness grafts harvested from the tail, which are known to have a higher probability for successful incorporation into the donor site compared to the skin harvested from the back13. This may be due to the lower number of epidermal Langerhans cells, which play a key role in cutaneous immunobiology, and are associated with the skin graft rejection14.
The proposed model of wound healing and graft integration may well be applied to transgenic and knockout mice. The use of genetically modified mice will assist in elucidating the roles that certain genes may play during wound repair. Exogenous application of topical wound preparations or subcutaneous administration of therapeutic antibodies at the site of the injury may also be considered.
Due to technical difficulties, split thickness skin grafts consisting of the epidermis and part of the dermis are difficult to obtain in mice. Full thickness skin grafts consisting of the epidermis and full thickness dermis are known to require a well-vascularized wound bed for successful integration. The inability to harvest split thickness skin grafts in mice may be regarded as a limitation of this model. The fixation of the skin graft to the recipient wound bed was achieved via the application of the surgical adhesive glue, which is associated with less trauma and rapid degradation compared to other means of tissue fixation15. Previous studies have shown that suturing is associated with stronger tissue fixation than the surgical glue at 24 h after the surgical procedure15, which may be considered as a disadvantage of the procedure. However, at later timepoints, the biomechanical strength of wounds treated with a surgical adhesive becomes comparable to sutures15 and better than staple fixation16. Following tissue fixation with the surgical glue, wounds must be covered with a wound dressing. Although wounds on the dorsal surface of the mouse are difficult for the animal to reach, the wound dressing, on the other hand, is easy for the animal to manipulate and remove. Frequent wound dressing changes may be warranted.
Anesthesia-induced hypothermia in small rodents is a well-documented phenomenon17. Hypothermia is a side effect of this procedure, which causes complications, and potentially compromises both animal health and data quality. Therefore, this method warrants the implementation of temperature management strategies, especially if hairless SKH1-Hrhr are used.
The most significant limitation of using mice to mimic human wound closure is the difference between the skin anatomy and physiology. Mouse wounds heal mostly via contraction, whereas human wounds heal through granulation tissue formation and re-epithelialization18. To account for this discrepancy, the current model may be modified and used in combination with a splinting ring tightly adhered around the wound to prevent skin contraction19. Given some advantages and disadvantages of this in vivo protocol, this model could serve as a tool to study certain processes involved in wound healing that are impossible to study in vitro.